Guangxi Chlor-Alkali Chemical has selected Solvay’s proprietary hydrogen peroxide technology for its new plant in China. Under the license agreement, Solvay will also provide a dedicated process design package, operating expertise and a range of services for the project.

Ineos Styrolution and Agilyx have plans to establish a 100 tons per day chemical recycling facility for polystyrene in Illinois, USA. At the plant, polystyrene will be converted back into high purity styrene monomer, these circular solutions are in high demand amongst industrial customers.

With the takeover of the global, commercial-stage biopharmaceutical company Amryt Pharma, Chiesi will be able to expand its capabilities and develop new treatments to patients living with rare diseases.

ETW Energietechnik’s Smartcool LCO2 plant can be perfectly integrated into the ETW Smartcycle biomethane plant so that the full value of biogas can be accessed.

Under a MOU signed between both the parties, Leonardo and Siemens Digital Industries will work together to provide advanced cybersecurity solutions for IT or OT technologies specifically for digital and integrated industrial infrastructures.

Eneos Materials’ chemical plant will be using Yokogawa’s Autonomous Control AI technology after successfully testing the technology for a year. The solution has the potential to decrease environmental impact, achieve stable quality, and transform operations.

Evonik has started-up a new production plant for gas separation membranes in Austria. With a hefty investment of double-digit million-euros, the plant aims to meet the firm’s goal of increasing its sustainable Next Generation Solutions.

Emerson’s BM6X Series Slam-Shut valve has now been certified for use in hydrogen applications by Bureau Veritas Italia. This means that the valve can be used for gas transmission networks, regulating stations, and end use infrastructure.

An expert has forecasted that the continued rise of biopharma innovation in China is the big macro trend in the APAC region for 2023. This market scenario has the potential to shift outsourcing and manufacturing strategies within the region.

Under the terms of the partnership, Solvay will acquire a Ginkgo laboratory in Massachusetts, USA which will help the company to expand its R&I footprint in the country and also accelerate the development of new sustainable biopolymers.